Oncology & Cancer
New glioblastoma cancer vaccine shows promise in phase 2 trial
The first results of a multicenter Phase 2 clinical trial on a new brain cancer vaccine tailored to a patient's own tumor will be announced on Monday at the American Society of Clinical Oncology (ASCO) 2011 Annual Meeting ...
Jun 6, 2011
0
0